v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 3,866 $ 3,954 $ 3,756
Cost of sales (3,335) (3,467) (3,388)
Gross margin 531 487 368
Selling, general and administrative expenses (207) (207) (188)
Restructuring and impairment, net (32) (5) (14)
Interest expense (15) (17) (14)
Interest income 17 10 4
Equity in net (loss) income of non-consolidated affiliates (3) (10) (1)
Other income (loss), net 7 (1) 20
Income (loss) before income taxes 298 257 175
Benefit from (provision for) income taxes (14) 248 (45)
Net income (loss) 284 505 130
Less: Net (income) loss attributable to non-controlling interests (10) (19) (6)
Net income (loss) attributable to Visteon Corporation $ 274 $ 486 $ 124
Basic earnings per share attributable to Visteon Corporation (in dollars per share) $ 9.93 $ 17.30 $ 4.41
Diluted earnings per share attributable to Visteon Corporation (in dollars per share) $ 9.82 $ 17.05 $ 4.35